Logo image of REPX

RILEY EXPLORATION PERMIAN IN (REPX) Stock Fundamental Analysis

USA - NYSEARCA:REPX - US76665T1025 - Common Stock

27.93 USD
+0.1 (+0.36%)
Last: 9/18/2025, 8:20:32 PM
27.93 USD
0 (0%)
After Hours: 9/18/2025, 8:20:32 PM
Fundamental Rating

6

REPX gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 210 industry peers in the Oil, Gas & Consumable Fuels industry. REPX has an excellent profitability rating, but there are some minor concerns on its financial health. REPX scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year REPX was profitable.
In the past year REPX had a positive cash flow from operations.
In multiple years REPX reported negative net income over the last 5 years.
Of the past 5 years REPX 4 years had a positive operating cash flow.
REPX Yearly Net Income VS EBIT VS OCF VS FCFREPX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

1.2 Ratios

REPX's Return On Assets of 9.26% is amongst the best of the industry. REPX outperforms 83.33% of its industry peers.
REPX's Return On Equity of 17.18% is fine compared to the rest of the industry. REPX outperforms 76.67% of its industry peers.
REPX has a better Return On Invested Capital (14.22%) than 90.95% of its industry peers.
The Average Return On Invested Capital over the past 3 years for REPX is above the industry average of 21.66%.
The last Return On Invested Capital (14.22%) for REPX is well below the 3 year average (23.68%), which needs to be investigated, but indicates that REPX had better years and this may not be a problem.
Industry RankSector Rank
ROA 9.26%
ROE 17.18%
ROIC 14.22%
ROA(3y)14.55%
ROA(5y)-8.31%
ROE(3y)26.42%
ROE(5y)-17.08%
ROIC(3y)23.68%
ROIC(5y)N/A
REPX Yearly ROA, ROE, ROICREPX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

The Profit Margin of REPX (24.36%) is better than 80.00% of its industry peers.
REPX has a Operating Margin of 44.11%. This is amongst the best in the industry. REPX outperforms 89.52% of its industry peers.
In the last couple of years the Operating Margin of REPX has grown nicely.
REPX has a Gross Margin of 73.72%. This is amongst the best in the industry. REPX outperforms 85.24% of its industry peers.
In the last couple of years the Gross Margin of REPX has grown nicely.
Industry RankSector Rank
OM 44.11%
PM (TTM) 24.36%
GM 73.72%
OM growth 3Y4.43%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.84%
GM growth 5Y19.4%
REPX Yearly Profit, Operating, Gross MarginsREPX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

4

2. Health

2.1 Basic Checks

REPX has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, REPX has more shares outstanding
REPX has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, REPX has an improved debt to assets ratio.
REPX Yearly Shares OutstandingREPX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
REPX Yearly Total Debt VS Total AssetsREPX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 1.99 indicates that REPX is not a great score, but indicates only limited risk for bankruptcy at the moment.
REPX's Altman-Z score of 1.99 is fine compared to the rest of the industry. REPX outperforms 67.14% of its industry peers.
The Debt to FCF ratio of REPX is 2.39, which is a good value as it means it would take REPX, 2.39 years of fcf income to pay off all of its debts.
REPX has a better Debt to FCF ratio (2.39) than 80.48% of its industry peers.
A Debt/Equity ratio of 0.46 indicates that REPX is not too dependend on debt financing.
REPX's Debt to Equity ratio of 0.46 is in line compared to the rest of the industry. REPX outperforms 51.90% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 2.39
Altman-Z 1.99
ROIC/WACC1.53
WACC9.28%
REPX Yearly LT Debt VS Equity VS FCFREPX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

2.3 Liquidity

REPX has a Current Ratio of 0.64. This is a bad value and indicates that REPX is not financially healthy enough and could expect problems in meeting its short term obligations.
REPX's Current ratio of 0.64 is on the low side compared to the rest of the industry. REPX is outperformed by 78.57% of its industry peers.
REPX has a Quick Ratio of 0.64. This is a bad value and indicates that REPX is not financially healthy enough and could expect problems in meeting its short term obligations.
REPX has a worse Quick ratio (0.60) than 75.24% of its industry peers.
Industry RankSector Rank
Current Ratio 0.64
Quick Ratio 0.6
REPX Yearly Current Assets VS Current LiabilitesREPX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 25.51% over the past year.
REPX shows a decrease in Revenue. In the last year, the revenue decreased by -4.93%.
REPX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 142.30% yearly.
EPS 1Y (TTM)25.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)-4.93%
Revenue growth 3Y39.52%
Revenue growth 5Y142.3%
Sales Q2Q%-18.98%

3.2 Future

The Earnings Per Share is expected to grow by 5.88% on average over the next years.
REPX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.21% yearly.
EPS Next Y14.21%
EPS Next 2Y13.71%
EPS Next 3Y5.88%
EPS Next 5YN/A
Revenue Next Year-3.86%
Revenue Next 2Y2.35%
Revenue Next 3Y3.21%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
REPX Yearly Revenue VS EstimatesREPX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
REPX Yearly EPS VS EstimatesREPX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2 4 6

9

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 4.58, which indicates a rather cheap valuation of REPX.
REPX's Price/Earnings ratio is rather cheap when compared to the industry. REPX is cheaper than 93.33% of the companies in the same industry.
REPX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.41.
With a Price/Forward Earnings ratio of 3.80, the valuation of REPX can be described as very cheap.
Based on the Price/Forward Earnings ratio, REPX is valued cheaply inside the industry as 97.14% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of REPX to the average of the S&P500 Index (22.88), we can say REPX is valued rather cheaply.
Industry RankSector Rank
PE 4.58
Fwd PE 3.8
REPX Price Earnings VS Forward Price EarningsREPX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, REPX is valued cheaply inside the industry as 86.19% of the companies are valued more expensively.
REPX's Price/Free Cash Flow ratio is rather cheap when compared to the industry. REPX is cheaper than 91.90% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.35
EV/EBITDA 3.48
REPX Per share dataREPX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

REPX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of REPX may justify a higher PE ratio.
PEG (NY)0.32
PEG (5Y)N/A
EPS Next 2Y13.71%
EPS Next 3Y5.88%

6

5. Dividend

5.1 Amount

REPX has a Yearly Dividend Yield of 5.44%, which is a nice return.
REPX's Dividend Yield is a higher than the industry average which is at 6.17.
Compared to an average S&P500 Dividend Yield of 2.38, REPX pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.44%

5.2 History

REPX has been paying a dividend for over 5 years, so it has already some track record.
REPX has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years3
Div Non Decr Years3
REPX Yearly Dividends per shareREPX Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

REPX pays out 33.70% of its income as dividend. This is a sustainable payout ratio.
DP33.7%
EPS Next 2Y13.71%
EPS Next 3Y5.88%
REPX Yearly Income VS Free CF VS DividendREPX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M
REPX Dividend Payout.REPX Dividend Payout, showing the Payout Ratio.REPX Dividend Payout.PayoutRetained Earnings

RILEY EXPLORATION PERMIAN IN

NYSEARCA:REPX (9/18/2025, 8:20:32 PM)

After market: 27.93 0 (0%)

27.93

+0.1 (+0.36%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners52.55%
Inst Owner Change-0.45%
Ins Owners5.12%
Ins Owner Change9.45%
Market Cap615.58M
Analysts82.5
Price Target64.26 (130.08%)
Short Float %3.58%
Short Ratio4.33
Dividend
Industry RankSector Rank
Dividend Yield 5.44%
Yearly Dividend1.47
Dividend Growth(5Y)N/A
DP33.7%
Div Incr Years3
Div Non Decr Years3
Ex-Date07-24 2025-07-24 (0.38)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)30.04%
Min EPS beat(2)-15.07%
Max EPS beat(2)75.15%
EPS beat(4)2
Avg EPS beat(4)13.95%
Min EPS beat(4)-68.25%
Max EPS beat(4)75.15%
EPS beat(8)3
Avg EPS beat(8)-6.87%
EPS beat(12)6
Avg EPS beat(12)2.52%
EPS beat(16)6
Avg EPS beat(16)-24.74%
Revenue beat(2)0
Avg Revenue beat(2)-3.79%
Min Revenue beat(2)-5.87%
Max Revenue beat(2)-1.72%
Revenue beat(4)0
Avg Revenue beat(4)-3.12%
Min Revenue beat(4)-5.87%
Max Revenue beat(4)-1.7%
Revenue beat(8)3
Avg Revenue beat(8)-0.23%
Revenue beat(12)7
Avg Revenue beat(12)36.59%
Revenue beat(16)11
Avg Revenue beat(16)37.49%
PT rev (1m)10.85%
PT rev (3m)10.85%
EPS NQ rev (1m)23.4%
EPS NQ rev (3m)-37.48%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)3.45%
Revenue NQ rev (3m)-6.54%
Revenue NY rev (1m)0.23%
Revenue NY rev (3m)-4.74%
Valuation
Industry RankSector Rank
PE 4.58
Fwd PE 3.8
P/S 1.57
P/FCF 5.35
P/OCF 2.77
P/B 1.11
P/tB 1.11
EV/EBITDA 3.48
EPS(TTM)6.1
EY21.84%
EPS(NY)7.34
Fwd EY26.29%
FCF(TTM)5.22
FCFY18.7%
OCF(TTM)10.1
OCFY36.15%
SpS17.83
BVpS25.27
TBVpS25.27
PEG (NY)0.32
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.26%
ROE 17.18%
ROCE 18.66%
ROIC 14.22%
ROICexc 14.44%
ROICexgc 14.44%
OM 44.11%
PM (TTM) 24.36%
GM 73.72%
FCFM 29.29%
ROA(3y)14.55%
ROA(5y)-8.31%
ROE(3y)26.42%
ROE(5y)-17.08%
ROIC(3y)23.68%
ROIC(5y)N/A
ROICexc(3y)24.26%
ROICexc(5y)N/A
ROICexgc(3y)24.26%
ROICexgc(5y)N/A
ROCE(3y)31.08%
ROCE(5y)N/A
ROICexcg growth 3Y1.22%
ROICexcg growth 5YN/A
ROICexc growth 3Y1.22%
ROICexc growth 5YN/A
OM growth 3Y4.43%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.84%
GM growth 5Y19.4%
F-Score6
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 2.39
Debt/EBITDA 1.01
Cap/Depr 137.12%
Cap/Sales 27.35%
Interest Coverage 6.56
Cash Conversion 88.43%
Profit Quality 120.27%
Current Ratio 0.64
Quick Ratio 0.6
Altman-Z 1.99
F-Score6
WACC9.28%
ROIC/WACC1.53
Cap/Depr(3y)429.72%
Cap/Depr(5y)307.72%
Cap/Sales(3y)65.26%
Cap/Sales(5y)47.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y14.21%
EPS Next 2Y13.71%
EPS Next 3Y5.88%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.93%
Revenue growth 3Y39.52%
Revenue growth 5Y142.3%
Sales Q2Q%-18.98%
Revenue Next Year-3.86%
Revenue Next 2Y2.35%
Revenue Next 3Y3.21%
Revenue Next 5YN/A
EBIT growth 1Y-15.77%
EBIT growth 3Y45.7%
EBIT growth 5YN/A
EBIT Next Year63.14%
EBIT Next 3Y19.44%
EBIT Next 5YN/A
FCF growth 1Y138%
FCF growth 3Y65.66%
FCF growth 5YN/A
OCF growth 1Y37.35%
OCF growth 3Y41.96%
OCF growth 5Y305.01%